WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Pro Bono
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Wilson Sonsini Advises USANA Health Sciences on Acquisition of Hiya Health
Client Highlights
December 23, 2024

On December 23, 2024, USANA Health Sciences announced the acquisition of a 78.8 percent controlling ownership stake in Hiya Health Products, a leading direct-to-consumer provider of high-quality children’s health and wellness products. The $205 million cash transaction was completed on the same date and is anticipated to be accretive to USANA’s 2025 adjusted EBITDA. Wilson Sonsini Goodrich & Rosati advised USANA on the transaction.

The strategic acquisition will broaden USANA's reach of health-conscious consumers and diversify the company's distribution channels. Hiya's co-founders Darren Litt and Adam Gillman will continue to lead the company.

The Wilson Sonsini team that advised USANA on the transaction includes:

Corporate/M&A
Marc Porter
Brian Keyes
Nikkisha Smith Howard
Austin Wolfe
Brayden Call
Michael Anderson

Capital Markets
Nathan Robinson

Antitrust and Competition
Jamillia Ferris
Kimberley Biagioli

FDA/Regulatory
Eva Yin

Regulatory
Stephen Heifetz
Seth Cowell
Anne Seymour
Bryan Poellot

Technology Transactions
Alex Key
Aleksandar Vitomirov
Kimberly Parry

Employment and Trade Secret Litigation
Matt Gorman
Quinn Christie

Employee Benefits and Compensation
Brandon Gantus
Michael Montfort
Jason Chan

Tax
Jonathan Zhu
Jason Sacks
Han Shen

Real Estate
James McCann
Moncarol Wang

Trademark
Aaron Hendelman
Chelsea Carbone

Data, Privacy, and Cybersecurity
Matthew Staples
Michael O'Brien
Dantam Le

Corporate - Delaware
Adrian Broderick
Sara Pollock

For more information, please see USANA’s news release.

Matter Leads

  • Marc Porter
  • Brian Keyes
  • Jamillia P. Ferris
  • Eva F. Yin
  • Stephen R. Heifetz
  • Alex Key
  • Matt Gorman
  • Brandon Gantus
  • Michael J. Montfort
  • Jonathan Zhu
  • James P. McCann
  • Aaron D. Hendelman
  • Matthew Staples
  • Adrian S. Broderick
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.